Antibody data
- Antibody Data
- Antigen structure
- References [2]
- Comments [0]
- Validations
- Western blot [1]
- ELISA [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- H00029780-M01 - Provider product page
- Provider
- Abnova Corporation
- Proper citation
- Abnova Corporation Cat#H00029780-M01, RRID:AB_463911
- Product name
- PARVB monoclonal antibody (M01), clone 4A11
- Antibody type
- Monoclonal
- Description
- Mouse monoclonal antibody raised against a full length recombinant PARVB.
- Antigen sequence
MKKDESFLGKLGGTLARKRRAREVSDLQEEGKNAI
NSPMSPALADVHPEDTQLEENEERTMIDPTSKEDP
KFKELVKVLLDWINDVLVEERIIVKQLEEDLYDGQ
VLQKLLEKLAGCKLNVAEVTQSEIGQKQKLQTVLE
AVHDLLRPRGWALRWSVDSIHGKNLVAILHLLVSL
AMHFRAPIRLPEHVTVQVVVVRKREGLLHSSHISE
ELTTTTEMMMGRFERDAFDTLFDHAPDKLSVVKKS
LITFVNKHLNKLNLEVTELETQFADGVYLVLLMGL
LEDYFVPLHHFYLTPESFDQKVHNVSFAFELMLDG
GLKKPKARPEDVVNLDLKSTLRVLYNLFTKYKNVE- Isotype
- IgG
- Antibody clone number
- 4A11
- Storage
- Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
Submitted references PARVB overexpression increases cell migration capability and defines high risk for endophytic growth and metastasis in tongue squamous cell carcinoma.
Expression of parvin-beta is a prognostic factor for patients with urothelial cell carcinoma of the upper urinary tract.
Eslami A, Miyaguchi K, Mogushi K, Watanabe H, Okada N, Shibuya H, Mizushima H, Miura M, Tanaka H
British journal of cancer 2015 Jan 20;112(2):338-44
British journal of cancer 2015 Jan 20;112(2):338-44
Expression of parvin-beta is a prognostic factor for patients with urothelial cell carcinoma of the upper urinary tract.
Wu CF, Ng KF, Chen CS, Chang PL, Chuang CK, Weng WH, Liao SK, Pang ST
British journal of cancer 2010 Sep 7;103(6):852-60
British journal of cancer 2010 Sep 7;103(6):852-60
No comments: Submit comment
Supportive validation
- Submitted by
- Abnova Corporation (provider)
- Main image
- Experimental details
- Western Blot analysis of PARVB expression in transfected 293T cell line by PARVB monoclonal antibody (M01), clone 4A11.Lane 1: PARVB transfected lysate(40.25 KDa).Lane 2: Non-transfected lysate.
Supportive validation
- Submitted by
- Abnova Corporation (provider)
- Main image
- Experimental details
- Detection limit for recombinant GST tagged PARVB is 1 ng/ml as a capture antibody.
- Validation comment
- Sandwich ELISA (Recombinant protein)
- Protocol
- Protocol